The CRISPR (clustered regularly interspaced short palindromic repeats) system is an adaptive immune system that targets viruses and other mobile genetic elements in bacteria and archaea. Cells store information of past infections in their genome in repeat-spacer arrays. After transcription, these arrays are processed into unit-length crRNA (CRISPR RNA) that is loaded into effector complexes encoded by Cas (CRISPR-associated) genes. CRISPR-Cas complexes target invading nucleic acid for degradation. CRISPR effector complexes have been classified into three main types (I-III). Type III effector complexes share the Cas10 subunit. In the present paper, we discuss the structures of the two Type III effector complexes from Sulfolobus solfataricus, SsoCSM (subtype III-A) and SsoCMR (subtype III-B), obtained by electron microscopy and single particle analysis. We also compare these structures with Cascade (CRISPR-associated complex for antiviral defence) and with the RecA nucleoprotein.
Introduction
In prokaryotes, CRISPRs (clustered regularly interspaced short palindromic repeats) are involved in an interference pathway that protects cells from bacteriophages and viruses. CRISPR sequences confer an adaptive heritable trace of past infections and express crRNAs (CRISPR RNAs), short RNAs that target 'non-self' nucleic acids. Cas (CRISPRassociated) proteins are integral players of the 'prokaryotic immune system' termed CRISPR-Cas defence. The Cas9 endonuclease CRISPR-Cas system has recently emerged as a powerful tool for genome editing in various cells and organisms.
CRISPR-Cas complexes have been extensively studied in recent times with structural biology methods to gain an insight into their molecular mechanism [1] . In Type III systems, Csm and Cmr proteins are known to form functional complexes involved in DNA and RNA targeting respectively. In the present paper, we discuss the structures of two archaeal interference complexes from Sulfolobus solfataricus, SsoCSM and SsoCMR, as determined by electron microscopy and single particle analysis. We highlight analogies and differences with the RecA structure, as well as with other CRISPR-Cas proteins for which structural information is available.
CRISPR-Cas complexes
The CRISPR-Cas prokaryotic defence consists of a multistep process whereby foreign nucleic acids are first recognized as being non-self and incorporated into the host genome Key words: clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated (Cas), CRISPR RNA (crRNA), RecA, RNA polymerase, Type III CRISPR. Abbreviations used: Cas, CRISPR-associated; Cascade, CRISPR-associated complex for antiviral defence; CRISPR, clustered regularly short interspaced palindromic repeats; crRNA, CRISPR RNA; RAMP, repeat-associated mysterious protein; Sso, Sulfolobus solfataricus. 1 To whom correspondence should be addressed (email laura.spagnolo@ed.ac.uk).
between short DNA repeats. These small fragments, in conjunction with host Cas proteins, are then used to recognize and destroy foreign nucleic acids. The dual tracrRNA (transactivating crRNA)-crRNA programmable Cas9 endonuclease of the Type II CRISPR-Cas system has proved to be an effective genome-editing tool in different cells and organisms [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] .
CRISPR-Cas systems are classified into Type I, Type II and Type III based on their phylogeny, sequence, locus organization and content of the CRISPRs and associated Cas genes [13] [14] [15] . The protein Cas3 is a signature of Type I systems, Cas9 is a signature of Type II systems, and Cas10 is a signature of Type III systems. These types are further divided into ten subtypes. Two Type III CRISPR-Cas complexes have been identified in the archaeon S. solfataricus. SsoCSM is a subtype III-A complex directed towards DNA. SsoCMR is a subtype III-B complex directed towards RNA.
Electron microscopy studies of the SsoCSM complex
The Sso subtype III-A effector complex, also known as the CSM complex, is associated with crRNA generated by cleavage of pre-crRNA following 5 -and 3 -end processing of pre-crRNA by Cas6 and an unknown nuclease [16] . The requirement for a mismatch region at the boundary of the repeat-spacer sequence ensures that the CRISPR locus in the host genome is not cleaved by subtype III-A systems [17] .
We solved the structure of the SsoCSM-RNA complex with electron microscopy coupled to single particle analysis [18] (Figure 1A) . The complex exhibits an elongated structure formed by two intertwined filaments connected at one end by a large base. Direct comparison with the bacterial Cascade (CRISPR-associated complex for antiviral defence) complex [19] reveals crucial analogies to the anatomy of Type I 
Figure 2 Fitting RecA into the map of the SsoCSM complex
RecA (PDB code 3CMW) was fitted into the electron microscopy map of the SsoCMR complex using the Chimera software [30] .
systems ( Figure 1B ). In particular, the backbone formed by six Cas7-proximal domains and the Cas5 subunit from the bacterial Cascade complex can be accurately superimposed to the RAMP (repeat-associated mysterious protein) subunits (Sso1427, four copies of Sso1426 and Sso1432) in CSM. Both pitch and height of the Cascade backbone are identical with that of CSM. SsoCSM is slightly longer than the bacterial Cascade (205 Å compared with 190 Å ; where 1 Å = 0.1 nm). The larger diameter of the major backbone is consistent with the presence of bound crRNA, probably in an orientation analogous to the one observed in Cascade. Consistent with the distinct structures of Cse1 and Cmr2, which are the large subunits of the Type I and Type III complexes, the bases of the two complexes are not structurally similar.
Structural similarities between the Cascade-RNA complex and the RecA-ssDNA nucleoprotein [20] have been highlighted previously [21, 22] . This comparison is very relevant with respect to the RecA mechanism of recognition of homologous dsDNA and strand exchange, where the protein wraps around the nucleic acid, in keeping an overlap of the two helical axes. We have therefore tested how the RecA crystallographic structure (PDB code 3CMW [20] ) fits into the CSM map (Figure 2) . In this case, we fitted both protein chains (A and C) from the PDB file, each of which is superimposable with one of the two coiled filaments in CSM. Pitch, height and filament width are consistent between RecA and the upper part of CSM. This could suggest a possible RNA/DNA-scanning and -recognition interface in correspondence of the crevice between CSM filaments. In fact, this cleft could well accommodate in length and width a 38 bp dsDNA target sequence, such as the Locus A spacer 26-abundant crRNA sequence identified in the CSM complex by deep sequencing [18] .
Electron microscopy studies of the SsoCMR complex
The electron microscopy structure of the CMR complex [23] (Figure 3 ) has no obvious similarity to the 'seahorse' structure of Escherichia coli Cascade [24] or to the RecA-ssDNA nucleoprotein [20] . CMR is structurally rather reminiscent of RNA polymerase [25] (Figure 3B ), as initially hypothesized with sequence analysis tools. In particular, its upper half is organized in a 'claw' region, which could be a dsRNAbinding cleft. This is in line with Cmr2 harbouring the active site of the CMR complex. The Cmr2-Cmr3-Cmr7 subcomplex, which contains no bound crRNA, has a deeper cleft in comparison with the full complex. The lack of crRNA in the Cmr2-Cmr3-Cmr7 subcomplex fits with a presumed role for the RAMP-containing Cmr subunits (Cmr1, Cmr4 and Cmr6) in RNA binding [14] . Compared with Cmr2-Cmr3-Cmr7, the additional Cmr subunits are distributed mainly at the front and at the tail of the complete CMR complex. Identification of the path of RNA in the CMR structure remains elusive; however, it will be vital to elucidate the molecular mechanism and organization of this complex.
Recent crystallographic work on CMR subunits has unveiled the structure of the Cmr7 dimer (Sso1986) [23] and of a truncation mutant of Cmr2 in isolation [26, 27] , as well as in complex with Cmr3 [28] . We tested fitting the related PDB files into the envelope of electron density to provide a model of how each of these subunits is arranged relative to each other in the Cmr2-Cmr3-Cmr7 subcomplex, as well as in the full CMR complex. Volumetric analysis of the sum of the volumes is consistent with the Cmr2-Cmr3-Cmr7 complex stoichiometry determined by densitometry (i.e. 1:1:6) [23] . Unfortunately, it was not possible to unequivocally fit the PDB files in the electron microscopy map because we lacked strong structural features that could guide this analysis. Positional mapping of CMR, which would be instrumental to understanding the interference mechanism for this complex, therefore remains elusive.
Comparison between SsoCSM and SsoCMR
The electron microscopy structure of the subtype III-B (CMR) structure appears very different from that of the subtype III-A complex, despite the fact that they share much clearer homology than either does with Cascade. The 'body' of the CMR complex is composed of a number of RAMPdomain proteins (Cmr1, Cmr4, Cmr5 and Cmr6) that are assumed to bind RNA. However, they are not obviously arranged in the helical conformation seen for the Type I and subtype III-A complexes, but appear to form a more compact structure [29] . This may reflect the fact that CMR targets flexible RNA substrates, rather than rigid helical dsDNA. The mechanism of molecular recognition for these effectors could therefore be expected to differ fundamentally and be reflected in their distinct structures.
Conclusions
Structural studies of CRISPR-Cas assemblies has proven a very productive field in recent times [1] . Structural electron microscopy is a powerful technique to identify and analyse similarities and differences between the large complexes classified in each type, therefore providing hints for future studies aimed at deciphering the molecular mechanisms involved in every process. A key feature that many CRISPR-Cas complexes have in common is the presence of a backbone (sometimes compared with a 'spine' in the anatomy of the complex), which binds the RNA component of the ribonucleoprotein. Higher-resolution comparative structural studies will help to unravel how these backbones differ and how these differences are related to each functional mechanism. CRISPR-Cas systems have been utilized for efficient genome editing [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . Understanding their structure at the molecular level bears a strong potential to optimize their use for applications such as gene therapy.
